Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial

Aditya H. Gaur, Mark F. Cotton, Carina A. Rodriguez, Eric McGrath, Elizabeth Helström, Afaaf Liberty, Eva Natukunda, Pope Kosalaraksa, Kulkanya Chokephaibulkit, Heather Maxwell, Pamela Wong, Danielle Porter, Sophia R. Majeed, Mun Sang Yue, Hiba Graham, Hal Martin, Diana M. Brainard, Cheryl Pikora